Obtusifoliol
CAS No. 16910-32-0
Obtusifoliol( —— )
Catalog No. M21736 CAS No. 16910-32-0
Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameObtusifoliol
-
NoteResearch use only, not for human use.
-
Brief DescriptionObtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).
-
DescriptionObtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).
-
In VitroObtusifoliol (0.1-100 μM; 48 hours) inhibit MCF-7 and MDA-MB231 breast cancer cells proliferation via arresting cell cycle progression and induction of apoptosis. Cell Viability Assay Cell Line:MCF-7; MDA-MB231 breast cancer cells Concentration:0.1, 1, 10, 40, 80, and 100 μM Incubation Time:48 hours Result:Inhibited MCF-7 and MDA-MB231 breast cancer cells proliferation.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16910-32-0
-
Formula Weight426.729
-
Molecular FormulaC30H50O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@@H]1CC[C@@](C)2[C@@]([H])([C@H]1C)CCC1=C2CC[C@](C)2[C@]([H])([C@@H](C)CCC(=C)C(C)C)CC[C@@]21C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Citiolase
Citiolone is a thiolic-derived medication as a mucolytic agent for the treatment of certain hepatic disorders.
-
CRCD2
1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- may have antitumor activity.
-
Mogroside III-A2
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
Cart
sales@molnova.com